NuVasive Inventory Turnover Ratio 2006-2019 | NUVA
NuVasive inventory turnover ratio from 2006 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
| NuVasive Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.890B | $1.102B |
| NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $151.583B | 20.94 |
| Abbott Laboratories (ABT) | United States | $151.168B | 27.57 |
| Stryker (SYK) | United States | $76.313B | 25.66 |
| Boston Scientific (BSX) | United States | $61.440B | 29.00 |
| Baxter (BAX) | United States | $42.463B | 25.75 |
| Essilor Luxottica (ESLOY) | France | $33.468B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.550B | 19.17 |
| Terumo (TRUMY) | Japan | $27.062B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.531B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.294B | 39.03 |
| ResMed (RMD) | United States | $21.653B | 39.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.279B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $19.151B | 0.00 |
| Insulet (PODD) | United States | $11.373B | 541.06 |
| Bio-Rad Laboratories (BIO) | United States | $11.201B | 53.76 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $7.531B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.203B | 21.24 |
| Perrigo (PRGO) | Ireland | $7.117B | 13.27 |
| Canopy Growth (CGC) | Canada | $6.501B | 0.00 |
| Haemonetics (HAE) | United States | $6.146B | 41.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.743B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 0.00 |
| ICU Medical (ICUI) | United States | $3.830B | 24.97 |
| Neogen (NEOG) | United States | $3.545B | 59.33 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.165B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.121B | 0.00 |
| Quidel (QDEL) | United States | $2.954B | 28.04 |
| Aurora Cannabis (ACB) | Canada | $2.648B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.432B | 54.89 |
| Agios Pharmaceuticals (AGIO) | United States | $2.411B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.577B | 0.00 |
| InMode (INMD) | Israel | $1.516B | 0.00 |
| AtriCure (ATRC) | United States | $1.226B | 0.00 |
| Aphria (APHA) | $1.187B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.162B | 23.28 |
| Phibro Animal Health (PAHC) | United States | $0.994B | 18.61 |
| NanoString Technologies (NSTG) | United States | $0.944B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.802B | 20.04 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.771B | 29.55 |
| TG Therapeutics (TGTX) | United States | $0.709B | 0.00 |
| Quanterix (QTRX) | United States | $0.705B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.698B | 39.25 |
| PetIQ (PETQ) | United States | $0.675B | 16.46 |
| Omeros (OMER) | United States | $0.655B | 0.00 |
| Cerus (CERS) | United States | $0.574B | 0.00 |
| Surmodics (SRDX) | United States | $0.570B | 59.24 |
| HEXO (HEXO) | $0.537B | 0.00 | |
| OraSure Technologies (OSUR) | United States | $0.492B | 29.52 |
| Owens & Minor (OMI) | United States | $0.474B | 17.53 |
| MacroGenics (MGNX) | United States | $0.474B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.405B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.396B | 28.71 |
| Meridian Bioscience (VIVO) | United States | $0.396B | 13.62 |
| BioLife Solutions (BLFS) | United States | $0.331B | 134.92 |
| Zynex (ZYXI) | United States | $0.329B | 37.22 |
| Bovie Medical (APYX) | United States | $0.275B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.269B | 0.00 |
| United Health Products (UEEC) | United States | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.242B | 25.52 |
| Vapotherm (VAPO) | United States | $0.227B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.195B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.192B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.164B | 0.00 |
| Chimerix (CMRX) | United States | $0.151B | 0.00 |
| Female Health (VERU) | United States | $0.148B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.141B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.128B | 9.03 |
| MTech Acquisition (KERN) | United States | $0.114B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 23.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.080B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
| Nephros (NEPH) | United States | $0.064B | 0.00 |
| Surface Oncology (SURF) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.017B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.013B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
